Stephanie Pacheco
Medical · Houston, TXNPI 1396061420
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.
Across 100 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$303
- Novo Nordisk$176
- Lilly USA, LLC$172
- AbbVie$146
- Abbott$124
- Bayer$122
- plus $835 from 23 others
What the payments were for
- Food & beverage$1,878100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $303 |
| Novo Nordisk | 13 | $176 |
| Lilly USA, LLC | 10 | $172 |
| AbbVie | 8 | $146 |
| Abbott | 6 | $124 |
| Bayer | 5 | $122 |
| Amgen | 7 | $117 |
| Pfizer | 4 | $100 |
| Boehringer Ingelheim | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 2 | $55 |
| GSK | 3 | $55 |
| Biohaven Pharmaceuticals, Inc. | 2 | $48 |
| Stryker | 1 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Exact Sciences | 2 | $34 |
| Shield Therapeutics Inc | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Eisai Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Cequr Corporation | 1 | $20 |
| Antares Pharma, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Tempus AI, Inc | 1 | $18 |
| Medline Industries LP | 1 | $18 |
| Biosense Webster, Inc. | 1 | $18 |
| Genentech USA, Inc. | 2 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Optinose US, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
How this compares
$1,878 in reported general payments places this provider in the 65th percentile of 1,490 medical providers in Texas.
Other medical in Houston
- Olga RodziyenskaHouston$65K
- Kathleen HoganHouston$26K
- Omni McCluneyHouston$18K
- Carl MayberryHouston$18K
- Carley BuddenbaumHouston$16K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.